1140 Relaxin as a potential diagnostic biomarker for ovarian cancer- a prospective study | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

1140 Relaxin as a potential diagnostic biomarker for ovarian cancer- a prospective study

Free

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

	Abstract	Full	Pdf
Oct 2021	82	0	18
Nov 2021	28	0	7
Dec 2021	16	0	3
Jan 2022	29	0	6
Feb 2022	14	0	0
Mar 2022	16	0	4
Apr 2022	9	0	6
May 2022	14	0	9
Jun 2022	10	0	4
Jul 2022	20	0	3
Aug 2022	16	0	4
Sep 2022	22	0	7
Oct 2022	20	0	6
Nov 2022	10	0	2
Dec 2022	28	0	3
Jan 2023	27	0	10
Feb 2023	28	0	0
Mar 2023	14	0	1
Apr 2023	4	0	1
May 2023	10	0	0
Jun 2023	2	0	0
Jul 2023	6	0	6
Aug 2023	12	0	3
Sep 2023	4	0	1
Oct 2023	4	0	0
Nov 2023	16	0	2
Dec 2023	27	0	0
Jan 2024	14	0	0
Feb 2024	10	0	2
Mar 2024	26	0	1
Apr 2024	12	0	0
Total	550	0	109